Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination therapy consisting of Buxue Yimu Pills (a traditional Chinese medicine) and ferrous sulfate used to treat iron deficiency anemia, particularly gynecological anemia in women. This combination therapy has been studied in clinical trials to evaluate its efficacy compared to either component alone. Buxue Yimu Pills consist of multiple Chinese herbs including Angelica Sinensis, Astragalus, Donkey-Hide Gelatin, Herba Leonuri, and Citrus, which are traditionally used to replenish qi and blood and dispel blood stasis. Ferrous sulfate, on the other hand, is a common iron supplement used to treat iron deficiency anemia by providing the body with iron needed to produce red blood cells. When combined, Buxue Yimu Pills and ferrous sulfate have shown effectiveness in treating gynecological anemia. The mechanism of action for this combination appears to involve both direct iron supplementation from ferrous sulfate and the multi-target effects of Buxue Yimu Pills, which may include inhibition of inflammation and oxidative stress, promotion of hematopoiesis, and optimization of iron redistribution.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on buxue yimu pills + ferrous sulfate.